Background: Neurosarcoidosis is an inflammatory granulomatous disease. Up to 25% of occult sarcoidosis affecting the nervous system are only detected by autopsy. In addition, in recent years the suspicion arose that the soluble Interleukin-2 Receptor (sIL-2R) might be useful in differentiating between neurosarcoidosis and neurosarcoidosis-like diseases such as neurotuberculosis, multiple sclerosis, or cerebral lymphoma.

Objectives: Therefore, we aimed to systematically review randomized controlled trials (RCT), observational studies, and case-control studies evaluating sIL-2R levels in neurosarcoidosis patients.

Design: For this systematic review, a comprehensive literature search of electronic databases including EMBASE, The Web Of Science, The Cochrane Library, MEDLINE, and Google Scholar was conducted. The search was limited to the English language and publication date up to January 08 2024.

Data Sources And Methods: As part of the search strategy conducted, 6 articles met the inclusion criteria. Two independent reviewers extracted the relevant data from each article. In addition, 2 independent reviewers assessed the quality of each study using the Newcastle-Ottawa Scale (NOS).

Results: We included 6 studies comprising 98 patients suffering from neurosarcoidosis, 525 non-sarcoidosis patients, and 118 healthy controls. Included studies were published between 2010 and 2023. Cerebrospinal fluid (CSF) sIL-2R levels differed significantly between neurosarcoidosis patients and multiple sclerosis, vasculitis, and healthy controls whereas serum sIL-2R levels did not reveal sufficient discriminative power. sIL-2R index was able to discriminate neurosarcoidosis from neurotuberculosis, bacterial/viral meningitis, and healthy controls.

Conclusions: In this systematic review, we found indications that sIL-2R may be a useful biomarker for the diagnosis of neurosarcoidosis. To determine an additional diagnostic value of sIL-2R, large prospective studies are needed that not only examine absolute sIL-2R levels in serum or CSF but also the dynamic changes as well as the implications of renal function on sIL-2R levels.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11348353PMC
http://dx.doi.org/10.1177/11795735241274186DOI Listing

Publication Analysis

Top Keywords

sil-2r levels
20
systematic review
12
sil-2r
9
soluble interleukin-2
8
interleukin-2 receptor
8
patients suffering
8
neurosarcoidosis
8
suffering neurosarcoidosis
8
multiple sclerosis
8
independent reviewers
8

Similar Publications

A novel prediction model for the prognosis of non-small cell lung cancer with clinical routine laboratory indicators: a machine learning approach.

BMC Med Inform Decis Mak

November 2024

Clinical Medical Center of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.

Background: Lung cancer is characterized by high morbidity and mortality due to the lack of practical early diagnostic and prognostic tools. The present study uses machine learning algorithms to construct a clinical predictive model for non-small cell lung cancer (NSCLC) patients.

Methods: Laboratory indices of the NSCLC patients at their initial visit were collected for quality control and exploratory analysis.

View Article and Find Full Text PDF
Article Synopsis
  • Non-Hodgkin lymphoma (NHL) can resemble soft tissue tumors, making pre-biopsy diagnosis difficult; this study aimed to determine the effectiveness of serum soluble interleukin-2 receptor (sIL-2R) levels and MRI in diagnosing soft tissue NHL.* -
  • Researchers analyzed 36 cases of confirmed soft tissue NHL alongside 48 control cases and found that combining MRI results (homogeneous appearance) and elevated sIL-2R levels effectively identified soft tissue NHL with high sensitivity and specificity.* -
  • The study concluded that using both MRI and sIL-2R measurements together provides a reliable method for predicting soft tissue NHL, enhancing diagnostic accuracy compared to conventional tumor evaluations.*
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to explore how levels of soluble interleukin-2 receptor (SIL-2R), endothelial nitric oxide synthase (eNOS), and cluster of differentiation 93 (CD93) in cerebrospinal fluid and serum relate to the severity and outcome of viral encephalitis (VE) in children.
  • 102 children diagnosed with VE were analyzed based on disease severity and prognosis, and compared to a control group of children without VE symptoms.
  • Results showed that elevated levels of these markers are linked to worse outcomes, and combining these measures improves the prediction of prognosis compared to using them individually.
View Article and Find Full Text PDF

Despite an emphasis on the prognostic impact of serum soluble interleukin-2 receptor (sIL-2R) at diagnosis in patients with diffuse large B-cell lymphoma (DLBCL), whether the prognostic impact of elevated sIL-2R is linear remains unclear. To verify the presence of a non-linear association between sIL-2R level at diagnosis and overall survival (OS) in patients with newly diagnosed DLBCL, we conducted a multi-center, observational retrospective study. Among 488 analyzable patients, Cox proportional hazards modeling identified serum sIL-2R level at diagnosis as an independent predictor of OS.

View Article and Find Full Text PDF

Objectives: Reports have shown that the kynurenine pathway, one of the pathways by which tryptophan is metabolized, is activated in patients with diffuse large B-cell lymphoma (DLBCL). Activation of the kynurenine pathway triggers the production of various metabolites, such as kynurenine (Kyn), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), kynurenic acid (KA), and anthranilic acid (AA), which contribute to immune tolerance. The current study aimed to investigate the changes in metabolites of kynurenine pathway in DLBCL patients and evaluate their performance predicting DLBCL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!